Detalhe da pesquisa
1.
A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer.
Gynecol Oncol
; 159(3): 692-698, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077258
2.
Cardiovascular and non-cardiovascular safety of dipeptidyl peptidase-4 inhibition: a meta-analysis of randomized controlled cardiovascular outcome trials.
Diabetes Obes Metab
; 18(3): 295-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26510994
3.
Protecting healthcare workers: A critical part of the COVID-19 response.
S Afr Med J
; 110(12): 1154-1155, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403955